SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-23-296813
Filing Date
2023-12-15
Accepted
2023-12-15 17:29:23
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B5 d633653d424b5.htm 424B5 503279
2 EX-FILING FEES d633653dexfilingfees.htm EX-FILING FEES 31786
3 GRAPHIC g633653g01k00.jpg GRAPHIC 40843
4 GRAPHIC g633653g46t55.jpg GRAPHIC 137055
  Complete submission text file 0001193125-23-296813.txt   773224
Mailing Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451
Business Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451 781-419-1400
Syndax Pharmaceuticals Inc (Filer) CIK: 0001395937 (see all company filings)

IRS No.: 320162505 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-254661 | Film No.: 231491488
SIC: 2834 Pharmaceutical Preparations